Sophiris Bio, Inc. (SPHS): Price and Financial Metrics
SPHS Price/Volume Stats
Current price | $0.00 | 52-week high | $0.05 |
Prev. close | $0.00 | 52-week low | $0.00 |
Day low | $0.00 | Volume | 1,000 |
Day high | $0.00 | Avg. volume | 0 |
50-day MA | $0.01 | Dividend yield | N/A |
200-day MA | $0.02 | Market Cap | 3.56K |
SPHS Stock Price Chart Interactive Chart >
Sophiris Bio, Inc. (SPHS) Company Bio
Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of products for the treatment of urological diseases. The company was formerly known as Protox Therapeutics Inc. and changed its name to Sophiris Bio, Inc. in April 2012. The company was founded in 2002 and is based in La Jolla, California.
Latest SPHS News From Around the Web
Below are the latest news stories about Sophiris Bio Inc that investors may wish to consider to help them evaluate SPHS as an investment opportunity.
The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&JThe following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 25.) Coherus Biosciences Inc (NASDAQ: CHRS ) The Medicines Company (NASDAQ: MDCO ) Down In The Dumps (Biotech stocks that hit 52-week lows Sept. 25.) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) Advaxis, Inc. (NASDAQ: ADXS ) AnaptysBio Inc (NASDAQ: ANAB ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) AzurRx BioPharma Inc (NASDAQ: AZRX ) ( announced lackadaisical efficacy data for pancreatic insufficiency drug) BridgeBio Pharma Inc (NASDAQ: BBIO ) Calithera Biosciences Inc (NASDAQ: CALA ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Cellectis SA (NASDAQ: CLLS ) CytomX Therapeutics Inc (NASDAQ: CT... |
SPHS Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | 0.00% |
5-year | 0.00% |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | 0.00% |
2020 | -96.35% |
2019 | -55.42% |
Loading social stream, please wait...